Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH)

Hepatology Research

Volumn 33, Issue 2, 2005, Pages 92-96

  Agarwal, Naresh ^a   Sharma, Barjesh Chander ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

Diabetes; Hyperinsulinemia; Hyperlipidemia; Non alcoholic fatty liver; Obesity; Steatosis

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA TOCOPHEROL; AMIODARONE; ATORVASTATIN; BEZAFIBRATE; COLESEVELAM; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; METFORMIN; METHOTREXATE; NUCLEOSIDE ANALOG; PENTOXIFYLLINE; PROTEIN TYROSINE KINASE; S ADENOSYLMETHIONINE; TAMOXIFEN; TUMOR NECROSIS FACTOR ANTIBODY;

AGE; ARTICLE; CELIAC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ETHNIC DIFFERENCE; HEPATOSPLENOMEGALY; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIFESTYLE; LIPODYSTROPHY; LIPOMATOSIS; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; OLIGOMENORRHEA; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PANNICULITIS; PATHOGENESIS; PHYSICAL EXAMINATION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SLEEP APNEA SYNDROME; WILSON DISEASE;

EID: 29144476444     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2005.09.012     Document Type: Article

References (24)

1. J. Ludwig T.R. Viggiano D.B. Mc Gill B.J. Ott Non-alcoholic steatohepatitis Mayo Clin Proc 55 1980 434-438
2. S.R. Cairns T.J. Peters Biochemical analysis of hepatic lipid in alcoholic and diabetic and control subjects Clin Sci 65 1983 645-652
3. N. Ruderman D. Chisholm X. Pi-sunyer S. Shneider The metabolically obese, normal weight individuals revisited Diabetes 47 1998 699-713
4. J.F. Silverman W.J. Pories J.F. Caro Liver Pathology in diabetes mellitus and morbid obesity: Clinical, pathological and biochemical considerations Pathol Annu 24 1989 275-302
5. N. Assy K. kaita D. Mymin C. Levy B. Rosser G. Minuk Fatty infiltration of liver hyperlipidemia patients Dig Dis Sci 45 2000 1929-1934
6. S. Chitturi G.C. Farrell Etiopathogenesis of nonalcoholic steatohepatitis Semin Liver Dis 21 2001 27-41
7. G.S. Hotamisligil P. Arner J.F. Caro R.L. Atkinson B.M. Spiegelmen Increase adipose tissue expression of tumor necrosis factor-α a in human obesity and insulin resistance J Clin Invest 95 1995 2409-2415
8. A.D. Baldridge A.R. Peres-Atayde F. Graeme-Cook L. Higgins J.E. Lavine Idiopathic steatohepatitis in childhood: A multicentric retrospective study J Pediatr 127 1995 700-704
9. C.A. Matteoni Z.M. Younossi T. Gramlich N. Boparai Y.C. Liu A.J. Mc Cullough Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity Gastroenterology 116 6 1999 116-1413-9
10. H. Nomura S. Kashiwagi J. Hayashi W. Kajiyam S. Tani M. Goto et al. Prevalence of NASH in general population of Okinawa, Japan Jpn J Med 27 1998 142-149
11. I.R. Wanless J.S. Lentz Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors Hepatology 12 1990 1106-1110
12. V.M.D. Struben E.E. Hespenheide S.H. Caldwell Non alcoholic steatohepatitis and cryptogenic cirrhosis within kindreds Am J Med 108 2000 9-13
13. S. Daniel T. Ben-Menachem G. Vasudevan C.K. Ma M. Blumankehl Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients Am J Gastroenterol 94 1999 3010-3014
14. P. Angulo J.C. Keach K.P. Batts K.D. Lindor Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Hepatology 30 1999 1356-1362
15. V. Ratziu P. Giral F. Charlotte et al. Liver fibrosis in overweight patients Gastroenterolgy 118 2000 1117-1123
16. A.E. Joseph S.H. Saverymuttu S. al-sam M.G. Cook J.D. Maxwewll Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease Clin Radiol 43 1991 26-31
17. M.R. Teli O.F.W. James A.D. Burt M.K. Bennett C.P. Day The natural history of nonalcoholic fatty liver: A follow up study Hepatology 22 1995 1714-1719
18. A. Propst T. Propst G. Zangerl G. Judmaier W. Vogel Prognosis and life expectancy in chronic liver disease Dig Dis Sci 40 1995 1805-1815
19. M. Charlton P. Kasparova S. Weston et al. Frequency of non alcoholic steatohepatitis as a cause of advanced liver disease Liver Transpl 7 2001 608-614
20. T Anderson C. Gluud M.B. Franzmann P. Christoffersen Hepatic effects of dietary weight loss in morbidly obese subjects J Hepatol 12 1991 224-229
21. C.S. Fu K. Esrason N.S. Alshak C.N. Conteas V.J. Simmons Dietary lecithin, anti-oxidants and vitamin B complex (LAB) decease hepatic steatosis in patients with NASH Gastroenterology 114 1998 A1243
22. S.K. Satpathy S. Garg R. Chauhan et al. Beneficial Effects of Tumor Necrosis Factor-α Inhibition by Pentoxiphyllin on Clinical, Biochemical and Metabolic Parameters of Patients with Non-alcoholic Steatohepatitis Am J Gastroenterol 99 2004 1946-1952
23. N. Mendez-Sanchez V. Gonzalez R. Pichardo- Bahena M. Uribe Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease: A randomized, double blind, placebo controlled trial Hepatology 3 2002 412A
24. M.J. Contos W. Cales R.K. Sterling et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis Liver Transpl 7 2001 363-373